4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-22-000063
CIK 0001133416other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:30 AM ET
Size
5.9 KB
Accession
0001133416-22-000063
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2022-05-19$1.33/sh+5,000$6,650→ 65,000 total(indirect: By LLC)
Holdings
- 23,469
Common Stock
- 16,000(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:30 AM ET
- Size
- 5.9 KB